» Articles » PMID: 16113422

Bacteria in Exacerbations of Chronic Obstructive Pulmonary Disease: Phenomenon or Epiphenomenon?

Overview
Specialty Pulmonary Medicine
Date 2005 Aug 23
PMID 16113422
Citations 51
Authors
Affiliations
Soon will be listed here.
Abstract

Our understanding of the pathogenesis and consequences of acute exacerbations of chronic obstructive pulmonary disease (COPD) has increased considerably in the past decade. Several new lines of evidence support bacterial causation of approximately half of the exacerbations in COPD. Acquisition of new strains of bacterial pathogens in patients with COPD is associated with a substantial increase in risk of exacerbation. Bacterial pathogens are isolated in significant concentrations from bronchoscopic samples obtained during acute exacerbation. Neutrophilic airway inflammation is associated with isolation of bacterial pathogens from sputum. A specific immune response to the infecting strains of bacterial pathogens isolated from sputum during exacerbations has been demonstrated. Future work should strive to understand better the host-pathogen interaction that leads to an exacerbation and to develop novel therapeutic and preventive measures.

Citing Articles

Protective Effects from Prior Pneumococcal Vaccination in Patients with Chronic Airway Diseases during Hospitalization for Influenza-A Territory-Wide Study.

Kwok W, Lung D, Tam T, Yap D, Ma T, Tsui C Vaccines (Basel). 2024; 12(7).

PMID: 39066342 PMC: 11281690. DOI: 10.3390/vaccines12070704.


Case Report: Nocardia amamiensis Infection Leading to Worsening of Chronic Obstructive Pulmonary Disease Symptoms in an Elderly Man.

Kanakan A, Kumar A, Kaur U, Narwade P, Rain Z, Yadav N Am J Trop Med Hyg. 2023; 109(5):1137-1140.

PMID: 37696514 PMC: 10622473. DOI: 10.4269/ajtmh.23-0284.


COPD Phenotyping.

Christenson S Respir Care. 2023; 68(7):871-880.

PMID: 37353326 PMC: 10289620. DOI: 10.4187/respcare.11035.


Molecular Accounting and Profiling of Human Respiratory Microbial Communities: Toward Precision Medicine by Targeting the Respiratory Microbiome for Disease Diagnosis and Treatment.

Alsayed A, Abed A, Khader H, Al-Shdifat L, Hasoun L, Al-Rshaidat M Int J Mol Sci. 2023; 24(4).

PMID: 36835503 PMC: 9966333. DOI: 10.3390/ijms24044086.


Trends in the Bacterial Prevalence and Antibiotic Resistance Patterns in the Acute Exacerbation of Chronic Obstructive Pulmonary Disease in Hospitalized Patients in South India.

Ullah M, Malamardi S, Siddaiah J, A T, Prashant A, Vishwanath P Antibiotics (Basel). 2022; 11(11).

PMID: 36358232 PMC: 9686600. DOI: 10.3390/antibiotics11111577.